Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes

References

• Bruno G1, Maule M, Merletti F; . RIDI study group. Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes. 2010;59:2281–2287.
   PubMedGoogle Scholar
• Gómez-Díaz RA, Pérez-Pérez G, Hernández-Cuesta IT, et al. Incidence of type 1 diabetes in Mexico: data from an institutional register 2000–2010. Diabetes Care. 2012;35:e77.
   PubMed Web of Science ®Google Scholar
• Wu HB, Zhong JM, Hu RY, et al. Rapidly rising incidence of Type 1 diabetes in children and adolescents aged 0⁃19 years in Zhejiang, China, 2007 to 2013[J]. Diabet Med. 2016;33(10):1339⁃1346.
   Web of Science ®Google Scholar
• Nan X, Ke-jun L, Xue-fei G, et al. The research on total medical expenses of patients with diabetes [article in Chinese]. Chin Health Economics. 2016;35(10):65–68.
   Google Scholar
• The American Diabetes Association (ADA). Standards of medical care in diabetes-2022[J]. Diabetes Care. 2022 Jan;45(Suppl 1):S1–S264
   PubMedGoogle Scholar
• Di W, Chunxiu G, Meng X, et al. Glycemic control and management of type 1 diabetes mellitus children in Beijing during 10 years [article in Chinese]. Chin J Appl Clin Pediatr. 2013;28(14):1096–1098.
   Google Scholar
• Tauschmann M, Hermann JM, Freiberg C, et al. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3, 553 subjects from the DPV registry[J]. Diabetes Care. 2020;43(3):e40‐e42.
   PubMed Web of Science ®Google Scholar
• Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018[J]. Diabetes Technol Ther. 2019;21(2):66–72.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes[J]. N Engl J Med. 2005;353:2643–2653.
   PubMed Web of Science ®Google Scholar
• Harjutsalo V, Maric‐Bilkan C, Forsblom C, et al. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes[J]. Diabetes Care. 2014;37(1):144‐148.
   Web of Science ®Google Scholar
• Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register‐based cohort study[J]. Lancet. 2018;392(10146):477‐486.
   PubMed Web of Science ®Google Scholar
• Bode BW, Sabbah HT, Gross TM, et al. Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev. 2002;18:S14–20.
   PubMed Web of Science ®Google Scholar
• Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med. 2001;161:2293–2300.
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes[J]. N Engl J Med. 2010;363(4):311–320.
   PubMed Web of Science ®Google Scholar
• Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ. 2002;324:705.
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE diabetes model against epidemiological and clinical studies[J]. Curr Med Res Opin. 2004;20(1):S27–40.
   PubMed Web of Science ®Google Scholar
• Sicui H, Yang H, Chen Z, et al. Clinical outcome and cost-effectiveness analysis of CSII versus MDI in children and adolescent with type 1 diabetes mellitus in a public health care system of China[J]. Front Endocrinol (Lausanne). 2021 March;12:604028.
   PubMed Web of Science ®Google Scholar
• Beate Karges MD, Anke Schwandt MS, Bettina Heidtmann MD, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, pediatrics, and young adults with type 1 diabetes[J]. JAMA. 2017;318(14):1358–1366.
   PubMed Web of Science ®Google Scholar
• Duan X, Li C, Li YLQ. Epidemiological characteristics, medical cost and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus[J]. Value Health. 2018;21:S40.
   Web of Science ®Google Scholar
• Guoen L, Shanlian H, Jiuhong W, et al. China guidelines for pharmacoeconomic evaluations [books in Chinese]. Vol. 2020. China: China market press; 2020. p. 27.
   Google Scholar
• McEwan P, Foos V, James L, et al. Validation of the IMS CORE diabetes model[J]. Value Health. 2014;17:714–724.
   PubMed Web of Science ®Google Scholar
• St Charles M, Lynch P, Graham C, et al. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes adult patients: a third-party US payer perspective. Value Health. 2009;12(5):674–686.
   PubMed Web of Science ®Google Scholar
• Charles M S, Sadri H, Minshall M, et al. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada. Clin Ther. 2009;3(3):657–667.
   Google Scholar
• Doubova SV, Roze S, et al. Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican institute of social security. Cost Ef Resour Alloc. 2019;17(19):2–12. Doubova et al.
   PubMedGoogle Scholar
• Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization[J]. Diabetes. 1982;31(8):663–669.
   PubMed Web of Science ®Google Scholar
• Cummins E, Royle P, Snaith A et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010;14(11):iii–iv, xi–xvi, 1–181.
   Web of Science ®Google Scholar
• Cohen N, Minshall M, Sharon-Nash L, et al. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin. Pharmacoeconomics. 2007;25(10):881–897.
   PubMed Web of Science ®Google Scholar
• Ontario HQ. Continuous monitoring of glucose for type 1 diabetes: a health technology assessment[J]. Ont Health Technol Assess Ser. 2018;18(2):1–160.
   Google Scholar
• Beaudet A, Clegg J, O TP, et al. Review of utility values for economic modeling in type 2 diabetes[J]. Value Health. 2014;17(4):462–470.
   PubMed Web of Science ®Google Scholar